2007


1. Abraham S, Guo F, Li LS, Rader C, Liu C, Barbas CF, Lerner RA & Sinha SC
Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation.
Proc. Natl. Acad. Sci. USA 104 (2007) 5584-5589

2. Andryushkova AA, Kuznetsova IA, Bineva VN, Toporkova LB, Sakhno LV, Tikhonova MA, Chernykh ER, Orlovskaya IA & Nevinsky GA
Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors.
J. Cell. Mol. Med. 11 (2007) 531-551

3. Belogurov AA, Kurkova IN, Misikov VK, Suchkov SV, Telegin GB, Alekhine AI, Goncharov NG, Knorre VD, Gabibov AG & Ponomarenko NA
Substrate specificity of catalytic autoantibodies in neurodegenerative processes.
Dokl. Biochem. Biophys. 413 (2007) 61-64

4. Boucher G, Said B, Ostler EL, Resmini M, Brocklehurst K & Gallacher G
Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
Biochem. J. 401 (2007) 721-726

5. Brogan AP, Eubanks LM, Koob GF, Dickerson TJ & Janda KD
Antibody-catalyzed oxidation of delta(9)-tetrahydrocannabinol.
J. Am. Chem. Soc. 129 (2007) 3698-3702

6. De Lamo Marin S, Xu X, Meijler MM & Janda KD
Antibody catalyzed hydrolysis of a quorum sensing signal found in Gram-negative bacteria
Bioorg. Med. Chem. Lett. 17 (2007) 1549-1552

7. Dimitrov JD, Roumenina LT, Doltchinkova VR, Mihaylova NM, Lacroix-Desmazes S, Kaveri SV & Vassilev TL
Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions.
J. Biol. Chem. 282 (2007) 26696-26706

8. Fujii I
Directed evolution of antibody molecules in phage-displayed combinatorial libraries.
Yakugaku Zasshi 127 (2007) 91-99

9. Hifumi E, Morihara F, Hatiuchi K, Okuda T, Nishizono A & Uda T.
Catalytic features and eradication ability of antibody light chain UA15-L against H. pylori.
J.Biol. Chem. (2007) in press

10. Ino A, Dickerson TJ & Janda KD
Positional linker effects in haptens for cocaine immunopharmacotherapy.
Bioorg. Med. Chem. Lett. 17 (2007) 4280-4283

11. Jayasundera KP, Brodie SJ & Taylor CM
Synthesis of a transition-state analog for the hydrolysis of the zearalenone lactone.
Tetrahedron 63 (2007) 10077-10082

12. Karataeva NA & Nevinsky GA
Enzymes phosphorylating lipids and polysaccharides.
Biochemistry (Mosc) 72 (2007) 367-379

13. Kurita R, Yokota Y, Ueda A & Niwa O
Electrochemical surface plasmon resonance measurements in a microliter volume flow cell for evaluating the affinity and catalytic activity of biomolecules.
Anal. Chem. 79 (2007) 9572-9576

14. Lee EJ, Jang EJ, Lee E, Yu J, Chung HY & Jang YJ
Cell-penetrating autoantibody induces caspase-mediated apoptosis through catalytic hydrolysis of DNA.
Bioorg. Med. Chem. 15 (2007) 2016-2023

15. Leong MK, Chen C, Shar KC & Shiuan D
Selection and characterization of lipase abzyme from phage displayed antibody libraries.
Biochem. Biophys. Res. Commun. 361 (2007) 567-573

16. Lin F, Li Y, Yang WK, Liang B, Mu Y, Sun Y, Li W & Luo GM
Rapid selection of phage Se-scFv with GPX activity via combination of phage display antibody library with chemical modification.
Chem. Res. Chin. Univ. 23 (2007) 58-63

17. Ma X, Sun S, Ma X, Li T, Meng J & Fan J
Polyclonal antibodies from hen egg yolk (IgY) with hydrolysis activity.
Protein J. 26 (2007) 499-505

18. Marti S, Andres J, Moliner V, Silla E, Tunon I & Bertran J.
Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: An indirect effect produced during the maturation process.
Chemistry 14 (2007) 596-602

19. Marti S, Andres J, Silla E, Moliner V, Tunon I & Bertran J
Computer-aided rational design of catalytic antibodies: The 1F7 case.
Angew. Chem. Int. Ed. Engl. 46 (2007) 286-290

20. McKenzie KM, Mee JM, Rogers CJ, Hixon MS, Kaufmann GF & Janda KD
Identification and characterization of single chain anti-cocaine catalytic antibodies.
J. Mol. Biol. 365 (2007) 722-731

21. Mitsuda Y, Planque S, Hara M, Kyle R, Taguchi H, Nishiyama Y & Paul S
Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.
Mol. Biotechnol. 36 (2007) 113-122

22. Muller R, Debler EW, Steinmann M, Seebeck FP, Wilson IA & Hilvert D
Bifunctional catalysis of proton transfer at an antibody active site.
J. Am. Chem. Soc. 129 (2007) 460-461

23. Nishi Y, Yamamoto N, Shimazaki K, Takahashi-Ando N, Kakinuma H, Jialin S, Ruzheinikov SN, Muranova TA, Rice DW & Kajihara Y.
Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
J. Biochem. (Tokyo) 142 (2007) 421-433

24. Nishiyama Y, Karle S, Planque S, Taguchi H & Paul S
Antibodies to the superantigenic site of HIV-1 gp120: Hydrolytic and binding activities of the light chain subunit.
Mol. Immunol. 44 (2007) 2707-2718

25. Nishiyama Y, Mitsuda Y, Taguchi H, Planque S, Salas M, Hanson CV & Paul S
Towards covalent vaccination - Improved polyclonal hiv neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.
J. Biol. Chem. 282 (2007) 31250-31256

26. Oda M, Ito N, Tsumuraya T, Suzuki K, Sakakura M & Fujii I
Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
J. Mol. Biol. 369 (2007) 198-209

27. Okochi N, Kato-Murai M, Kadonosono T & Ueda M
Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
Appl. Microbiol. Biotechnol. 77 (2007) 597-603

28. Pagetta A, Tramentozzi E, Corbetti L, Frasson M, Brunati AM & Finotti P
Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects.
Mol. Immunol. 44 (2007) 2870-2883

29. Ponomarenko NA, Pillet D, Paon M, Vorobiev II, Smirnov IV, Adenier H, Avalle B, Kolesnikov AV, Kozyr AV, Thomas D, Gabibov AG & Friboulet A
Anti-idiotypic antibody mimics proteolytic function of parent antigen.
Biochemistry 46 (2007) 14598-14609

30. Rao D & Wootla B
Catalytic antibodies: concept and promise.
Resonance 12 (2007) 6-21

31. Reshetnyak AV, Armentano MF, Morse HC, Friboulet A, Makker SP, Tramontano A, Knorre VD, Gabibov AG & Ponomarenko NA
Mechanism-dependent selection of immunoglobulin gene library for obtaining covalent biocatalysts.
Dokl. Biochem. Biophys. 415 (2007) 179-182

32. Reshetnyak AV, Armentano MF, Ponomarenko NA, Vizzuso D, Durova OM, Ziganshin R, Serebryakova M, Govorun V, Gololobov G, Iii HC, Friboulet A, Makker SP, Gabibov AG & Tramontano A
Routes to covalent catalysis by reactive selection for nascent protein nucleophiles.
J. Am. Chem. Soc. 129 (2007) 16175-16182

33. Reymond JL
Substrate arrays for fluorescence-based enzyme fingerprinting and high-throughput screening.
Ann. N.Y. Acad. Sci. (2007) in press

34. Ricoux R, Raffy Q & Mahy JP
New biocatalysts mimicking oxidative hemoproteins: hemoabzymes.
C.R. Chimie 10 (2007) 684-702

35. Robertson MP & Scott WG
Designer enzymes.
Nature 448 (2007) 757-758

36. Sakakura M, Takahashi H, Shimba N, Fujii I & Shimada I
Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
J. Mol. Biol. 367 (2007) 133-147

37. Shamis M, Barbas CF & Shabat D
A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
Bioorg. Med. Chem. Lett. 17 (2007) 1172-1175

38. Simon L, Muniz FM, Saez S, Raposo C & Moran JR
From theozymes to artificial enzymes: Enzyme-like receptors for Michael additions with oxyanion holes and active amino groups.
Eur. J. Org. Chem. 2007 (2007) 4821-4830

39. Sinha SC, Das S, Li LS, Lerner RA & Barbas CF
Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.
Nat. Protoc. 2 (2007) 449-456

40. Suchkov SV, Vvedenskaia OI, Vostrikova IL, Gabibov AG, Kimova MV, Burdakova IA, Ponomarenko NA & Pal'tsev MA
Antibody-mediated proteolysis of myelin-associated proteins as a new mechanism of control over demyelinization processes in multiple sclerosis
Vestn. Ross. Akad. Med. Nauk. 2007 (2007) 32-36

41. Wang FY, Huang XY, Du L, Li WG, He HX & Qi C
Preparation and characterization of a chloroperoxidase-like catalytic antibody.
Int. J. Mol. Sci. 8 (2007) 445-454

42. Xu Y, Hixon MS, Yamamoto N, McAllister LA, Wentworth AD, Wentworth P & Janda KD
Antibody-catalyzed anaerobic destruction of methamphetamine.
Proc. Natl. Acad. Sci. USA 104 (2007) 3681-3686

43. Yoshida S, Shimada Y & Watanabe H
Novel approach toward infectious diseases.
Nippon Rinsho 65 (2007) 1715-1726




Retour